Advanced Biocompatibility: How to Comply with The New Requirements in ISO 10993 Series in a Simple Way and According to MDR

The recent release of ISO 10993-1:2018 and the upcoming Medical Device Regulation (MDR) General Safety and Performance Requirements (GSPR) bring new challenges for medical device manufacturers

Content
The recent release of ISO 10993-1:2018 and the upcoming Medical Device Regulation (MDR) General Safety and Performance Requirements (GSPR) bring new challenges for medical device manufacturers.

This course is structured to be hands-on and is designed for those who have a working knowledge of biocompatibility and are looking to update and sharpen their skills, in light of new updates and developments.

Led by a trainer with substantial experience in biocompatibility, chemical characterization and sterilization validation, the course will also be augmented with a Q&A session (via teleconference) from a certified toxicologist, as well as case studies provided both by the trainers and by notable Danish medical device manufacturers.  

Topics covered in this course:

  • Impact of the updated ISO 10993-1 (2018) for all types of devices (Class I, II, III, including transient skin contact). How should an appropriate biological risk assessment be prepared, including rationales for a reduced testing program.
  • Biocompatibility under MDR: Is ISO 10993 sufficient to effectively claim GSPR compliance? 
  • ISO 10993-18 (2020): A detailed look at this recently updated standard via practical workshops to choose proper tests, extracts and test duration. The workshops will include class led instruction, as well as multiple hands-on exercises for attendees to learn while being guided by an experienced instructor.
  • ISO 10993-17 and ISO TS 21726 (2019): Understanding how to perform toxicological risk assessments using TTCs
  • ISO 10993-7: EO Sterilization residuals, overview of the standard and current state of the art
  • Upcoming revisions of ISO 10993-12, ISO 10993-9, ISO 10993-7: what can we expect?

Target Group
This course is targeted at but not limited to:

  • Biosafety specialists
  • Biocompatibility specialists
  • Material specialists
  • Risk managers
  • Regulatory specialists and managers
  • Product design engineers
  • Clinical affair specialists and managers
  • Quality assurance specialists and managers

The course is at advanced level therefore it is recommended that participants have in-depth knowledge of the ISO 10993 Series.

Trainers
Don Pohl, Principal Product Development Strategist
NAMSA
Valeriane Levelut, Toxicologist, NAMSA
Joe Brinkman, Senior Technical Advisor, NAMSA

 

Det er ikke muligt at tilmelde sig dette arrangement i øjeblikket

Kontakt

mp@medicoindustrien.dks billede
Morten Petersen
Uddannelseskonsulent
49184703